Nate Crossett

Stock Analyst at Exane BNP Paribas

(1.97)
# 3,105
Out of 5,072 analysts
38
Total ratings
50%
Success rate
1.28%
Average return

Stocks Rated by Nate Crossett

Medical Properties Trust
Mar 12, 2025
Upgrades: Outperform
Price Target: $5$9
Current: $5.77
Upside: +55.98%
Omega Healthcare Investors
Feb 8, 2024
Upgrades: Neutral
Price Target: $30
Current: $45.82
Upside: -34.53%
Agree Realty
Dec 13, 2023
Downgrades: Neutral
Price Target: $64
Current: $75.14
Upside: -14.83%
NETSTREIT
Dec 13, 2023
Downgrades: Neutral
Price Target: $17
Current: $18.24
Upside: -6.80%
Realty Income
Dec 13, 2023
Upgrades: Outperform
Price Target: $63
Current: $57.14
Upside: +10.26%
Alexandria Real Estate Equities
Oct 11, 2023
Initiates: Neutral
Price Target: $108
Current: $53.57
Upside: +101.61%
Ventas
Oct 11, 2023
Initiates: Outperform
Price Target: n/a
Current: $80.08
Upside: -
Digital Realty Trust
Jul 28, 2023
Upgrades: Outperform
Price Target: $138
Current: $158.91
Upside: -13.16%
Prologis
Jul 20, 2023
Upgrades: Outperform
Price Target: $141
Current: $128.16
Upside: +10.02%
Gaming and Leisure Properties
Jun 14, 2023
Initiates: Outperform
Price Target: $63
Current: $43.30
Upside: +45.50%
Initiates: Underperform
Price Target: $42
Current: $41.08
Upside: +2.24%
Initiates: Outperform
Price Target: $41
Current: $28.83
Upside: +42.21%
Initiates: Outperform
Price Target: $29
Current: $31.47
Upside: -7.85%
Initiates: Underperform
Price Target: $74
Current: $67.39
Upside: +9.81%
Initiates: Outperform
Price Target: n/a
Current: $14.04
Upside: -
Initiates: Underperform
Price Target: $9.6
Current: $8.22
Upside: +16.79%
Initiates: Outperform
Price Target: $66
Current: $86.22
Upside: -23.45%
Initiates: Outperform
Price Target: $38
Current: $10.79
Upside: +252.18%
Initiates: Outperform
Price Target: $886
Current: $750.41
Upside: +18.07%
Downgrades: Hold
Price Target: $31$30
Current: $24.01
Upside: +24.95%
Initiates: Buy
Price Target: $21
Current: $9.78
Upside: +114.72%
Downgrades: Hold
Price Target: $21$25
Current: $9.30
Upside: +168.82%
Upgrades: Buy
Price Target: n/a
Current: $34.10
Upside: -